Data di Pubblicazione:
2022
Citazione:
Morbidity and mortality in men: Role of androgens / G. Fallara, E. Pozzi, C. Corsini, F. Belladelli, L. Boeri, P. Capogrosso, F. Montorsi, A. Salonia. - In: BAILLIERE'S BEST PRACTICE & RESEARCH. CLINICAL ENDOCRINOLOGY & METABOLISM. - ISSN 1521-690X. - 36:4(2022 Jul), pp. 101662.1-101662.13. [10.1016/j.beem.2022.101662]
Abstract:
In this narrative review we provide an overview of the current literature on male hypogonadism and related comorbidities, also depicting the role of testosterone therapy (TTh) in the various settings. Male hypogonadism has been associated with major comorbidities such as type 2 diabetes mellitus, obesity and cardiovascular diseases, promoting a vicious cycle that may lead to further hypogonadism. The biological underpinnings of this association are currently under investigations, but clearly emerges the relevance of the hypothalamic-pituitary–gonadal axis. Hypogonadism has also been associated with increased risk of mortality. As such, TTh has the potential to oppose these patterns and improve cardiovascular and metabolic health in hypogonadal men. Clinical and observational data suggest that in males with hypogonadism, TTh, together with lifestyle changes and diabetes medications, may improve glycemia, reduce risk of progression to diabetes and provides positive effects on cardiovascular risk. Conversely, available data does not fully support any increased risk of prostate cancer in men under TTh. Of clinical relevance, a possible harmful role of hypogonadal status in men with COVID-19 eventually emerged.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
cardiovascular; COVID-19; diabetes; hypogonadism; mortality; testosterone
Elenco autori:
G. Fallara, E. Pozzi, C. Corsini, F. Belladelli, L. Boeri, P. Capogrosso, F. Montorsi, A. Salonia
Link alla scheda completa: